Throughout this medical market research, the publisher analyzed 16 dental bone graft substitutes companies in Australia and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of Australian Dental Bone Graft Substitutes Market analysis, each of the market segments is also available for purchase as a stand-alone report, MedCore.
Markets Covered
Australian Dental Bone Graft Substitutes Market Insights
Overall, the Australia dental bone graft substitutes and other biomaterials market was valued at $29.2 million in 2020. This is expected to increase over the forecast period at a CAGR of 16.2% to reach $83.9 million in 2027.
An ongoing trend within the market for dental biomaterials is the increasing market share of allografts. Allografts have traditionally faced difficulty gaining regulatory approval in Australia. Increased demand from dental professionals, as well as the streamlining of the regulatory approval process, will help drive this market over the forecast period.
Geistlich, a globally recognized leader in regenerative materials, dominated the xenograft DBGS market in Australia. The company also attained the leading share of the rapidly growing dental barrier membrane market. Through the company’s own affiliate in Sydney, Geistlich has been able to maintain its market share.
While this MedSuite report contains all of Australian Dental Bone Graft Substitutes Market analysis, each of the market segments is also available for purchase as a stand-alone report, MedCore.
Markets Covered
- Dental Bone Graft Substitutes Market - MedCore
- Dental Barrier Membranes Market - MedCore
Australian Dental Bone Graft Substitutes Market Insights
Overall, the Australia dental bone graft substitutes and other biomaterials market was valued at $29.2 million in 2020. This is expected to increase over the forecast period at a CAGR of 16.2% to reach $83.9 million in 2027.
An ongoing trend within the market for dental biomaterials is the increasing market share of allografts. Allografts have traditionally faced difficulty gaining regulatory approval in Australia. Increased demand from dental professionals, as well as the streamlining of the regulatory approval process, will help drive this market over the forecast period.
Geistlich, a globally recognized leader in regenerative materials, dominated the xenograft DBGS market in Australia. The company also attained the leading share of the rapidly growing dental barrier membrane market. Through the company’s own affiliate in Sydney, Geistlich has been able to maintain its market share.
Table of Contents
Table of ContentsList of FiguresList of ChartsExecutive SummaryAustralia Dental Bone Graft Substitute and Other Biomaterials Market OverviewCompetitive AnalysisMarket TrendsMarket DevelopmentsMarkets IncludedKey Report UpdatesVersion HistoryAbbreviations
Research Methodology
Impact of COVID-19 on the Australia Dental Bone Graft Substitute and Other Biomaterials Market
Disease Overview
Product Assessment
Australia Dental Bone Graft Substitute and Other Biomaterials Market Overview
Dental Bone Graft Substitute Market
Dental Barrier Membrane Market
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Australian Biotechnologies
- BioHorizons
- Citagenix
- Datum Dental
- Dentsply Sirona
- Envista
- Geistlich
- Genoss
- Henry Schein
- Medtronic
- MTF
- NovaBone
- Osteogenics
- Straumann Group
- Tissue Banks
- Zimmer Biomet
